AOHA.F Rua Life Sciences Plc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.3027 EUR
Close of Nov 12, 2026
0.0965 0.3480
Market cap
EUR 18.8M
P/E
-
P/B
1.75x
ROE
-20.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2024.

Is AOHA.F undervalued?

Graham number

The Graham number of Rua Life Sciences Plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rua Life Sciences Plc fundamental analysis

No fundamental analysis for Rua Life Sciences Plc yet.

Rua Life Sciences Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rua Life Sciences Plc

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and …

Full company profile